Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colloidal Silver for COVID-19 Treatment
NCT04978025Unknown
- Sponsor
- Hôpital Universitaire Sahloul
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised trial of silver nanoparticles in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hôpital Universitaire Sahloul. Primary endpoint: Change of clinical status at 10 days. Status: unknown.
02
Drugs
silver nanoparticles
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04978025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04978025.